Dual receptor agonist
Acts on both GIP and GLP-1 receptors rather than only one pathway.
Lennox / RxInjection / 8 mg
Monthly supply / 8 mg
Tirzepatide.A powerful prescription option for sustainable weight care.
Tirzepatide is a once-weekly peptide treatment that activates two metabolic hormone pathways.
It is designed to reduce hunger, increase fullness, support blood-sugar regulation, and help eligible adults achieve meaningful weight loss alongside healthy lifestyle changes.
Introductory first month
$349$249/first month
After month one
$349/month
- Licensed provider review
- Prescription required
- Ongoing clinical support
Provider evaluation required · Prescription not guaranteed · Exact product and dosing are prescription-specific · Individual results vary
Licensed provider review+Prescription required+Ongoing clinical support+8 mg Injection+$249 first month+$349 ongoing+Licensed provider review+Prescription required+Ongoing clinical support+8 mg Injection+$249 first month+$349 ongoing+
What is Tirzepatide?
Dual-pathway support for personalized weight care.
Tirzepatide is a once-weekly peptide treatment that activates two metabolic hormone pathways.
It is designed to reduce hunger, increase fullness, support blood-sugar regulation, and help eligible adults achieve meaningful weight loss alongside healthy lifestyle changes.
Subcutaneous injection
Injected under the skin only as directed on the prescription label.
Individualized care
Dose changes depend on the prescribed product, response, and tolerability.
Potential benefits
Designed to support what matters to you.
- 01
Reduces hunger and food cravings
- 02
Helps you feel full sooner and longer
- 03
Supports meaningful weight loss
- 04
Promotes healthier blood-sugar regulation
- 05
Supports improvements in metabolic health
- 06
Provides a convenient weekly treatment routine
How it may work
Two hormone pathways. One personalized plan.
Tirzepatide activates both GIP and GLP-1 receptors. These hormone pathways help regulate appetite, fullness, digestion, and blood sugar. By influencing both pathways, tirzepatide can help people eat less while following a personalized weight-care plan.
Activates two pathways
Tirzepatide activates receptors for GIP and GLP-1, hormones involved in metabolic signaling.
May increase fullness
It can affect appetite signals, which may help some people eat less when paired with a care plan.
Slows stomach emptying
This effect can influence fullness, blood sugar, side effects, and absorption of some oral medicines.
Curious about the science?
Explore tirzepatide research and prescribing information.
Explore research related to how this treatment works and the biological processes it is designed to support.
Lennox online care
Three clear steps.
One care team.
First month$249Then $349/month if prescribed and continued.
See if tirzepatide may be right for you
-
01
Complete your health assessment
Share your health history, medicines, allergies, goals, and prior weight-care treatments in a private online form.
-
02
Get a licensed provider review
A provider decides whether tirzepatide is appropriate and discusses the exact product. A prescription is not guaranteed.
-
03
Receive ongoing care
If prescribed, use only as labeled and stay in contact about side effects, questions, and follow-up.
Safety first
Know what to ask.
Tirzepatide has important risks and is not right for everyone. Animal studies found thyroid C-cell tumors; it is unknown whether this occurs in humans. Do not use it with a personal or family history of medullary thyroid carcinoma or MEN 2.
- Review severe stomach symptoms and pancreatitis warning signs
- Discuss gallbladder, kidney, allergy, and low-blood-sugar risks
- Share all medicines, pregnancy plans, and upcoming procedures
- Get urgent help for a serious allergic reaction or severe symptoms
Common questions
FDA-approved tirzepatide products have specific indications, including certain adults with type 2 diabetes and certain adults with obesity or overweight plus a weight-related condition. The intended use depends on the exact product and your provider's evaluation.
Do not infer a weekly dose from the vial strength or this page. Dose, concentration, injection volume, timing, and any changes must come from your prescription label and provider.
Common effects with FDA-approved tirzepatide products include nausea, diarrhea, vomiting, constipation, stomach pain, and indigestion. Some reactions can be serious, so review the full safety information with your provider.
Yes. It slows stomach emptying and may affect absorption of oral medicines. The risk of low blood sugar can rise with insulin or certain diabetes medicines. Share every medicine and supplement with your provider.
Not necessarily. Tirzepatide is the active ingredient in those FDA-approved brand products, but the product dispensed depends on your prescription. Ask your provider and pharmacy to identify it. Compounded drugs are not FDA-approved.
Your next step
See if Tirzepatide care may fit you.
A licensed provider reviews your health before treatment is offered. A prescription is never guaranteed.
See if tirzepatide may be right for you